Qiagen Slumps on Decision to Stay Independent After Approaches

Bookmark
(Bloomberg) -- Qiagen NV slumped 26% in post-market trading in the U.S. after the Dutch molecular-testing firm ended discussions with potential acquirers, calling the proposals “not compelling,” an...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.